| Serial Number | 79377294 |
| Word Mark | HEALOME |
| Filing Date | Monday, February 27, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 11, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 11, 2025 |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, scientific research in the field of treatment of eye diseases, injuries and conditions, treatment of dermal diseases, injuries and conditions, and in the field of biomaterials science; industrial scientific analysis and research services in the fields of eye care products and wound care products; product research and development services; scientific and technological services and research services relating thereto, namely, scientific research in the field of treatment of eye diseases, eye injuries and eye conditions, treatment of dermal diseases, injuries and conditions, and in the field of biomaterials science; scientific research services for medical, biomedical and therapeutic purposes in the fields of ocular surface diseases, dry eye diseases, ocular surface injury, corneal wounds, glaucoma; medical and bioscience research services in the fields of ocular surface diseases, dry eye diseases, ocular surface injury, corneal wounds, glaucoma; biomedical research services; scientific research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; scientific research and development services relating to dermatology; scientific research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; scientific research and development services relating to the treatment of diseases and conditions; scientific research services relating to the treatment of eye diseases and conditions; therapeutic research services, namely, scientific research in the field of eye diseases and eye injury; advisory, consultancy and information services relating to all the aforesaid. |
| Goods and Services | Pharmaceutical preparations and substances and therapeutic pharmaceuticals for diseases, traumatic injury, perioperative care, and inflammation related to the eye; pharmaceutical preparations, substances and treatments in the nature of eye drops, solutions, gels, films impregnated with preparations for the treatment of ocular and dermal conditions, sterilized dressings, sprays, lubricants, and ointments used for treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatments in the nature of eye drops, solutions, gels, lubricants, and ointments used for treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatments in the nature of solutions, gels, films impregnated with preparations for the treatment of ocular and dermal conditions, sterilized dressings, sprays, and ointments used for treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatments in the nature of solutions, gels, films impregnated with preparations for the treatment of scars, wounds and orthopaedic conditions, and for use in medical aesthetics treatments, sterilized dressings, sprays, and ointments used for treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances, namely, eye drops, ocular lubricants, solutions, gels, films impregnated with preparations for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease, sterilized dressings, sprays, lubricants, and ointments for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels for medical eye care; therapeutic gels for medical eye care; gel and liquid drops, sprays, films for use as a delivery agent for drugs and for therapeutic pharmaceuticals, suspensions in the nature of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of ocular diseases and conditions, and substances in the nature of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of ocular diseases and conditions; gels, suspensions, and liquids in the nature of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of ocular diseases and conditions; gels, suspensions, liquids, and lubricants in the nature of pharmaceutical preparations and therapeutic preparations for the treatment of eye conditions and diseases; tear film substitutes to provide lubrication, provide protection, support homeostasis, and for use as a delivery agent for drugs and supplements in the treatment of ocular conditions; tear film substitutes to provide lubrication, provide protection, support homeostasis, and for use as a delivery agent for drugs and supplements for the treatment of eye conditions and diseases; gels, suspensions, liquids, and lubricants in the nature of pharmaceutical preparations and therapeutic preparations for the treatment of eye conditions, namely, glaucoma, cataracts, amblyopia, age-related macular degeneration and diabetes-related retinopathy; gels, suspensions in the nature of pharmaceutical preparations and therapeutic pharmaceuticals, and liquids for medical and therapeutic use, namely, for treating eye diseases, treating traumatic eye injury, and used in perioperative eye care; eye drops; eye ointment for medical use; medicated eye-washes; eye lotions for medical use; lubricating eye drops; medicated liquids for the treatment of ocular diseases and conditions; medicated ocular lubricants; tear film substitutes being pharmaceutical preparations for the treatment of ocular diseases, injuries and conditions; tear substitutes, namely, artificial tears for ocular diseases and conditions; tear film substitutes, being pharmaceutical preparations in the form of eye drops, solutions, gels, sprays, lubricants, ointments and artificial tears for treatment of ocular diseases and conditions |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 25, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 25, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Healome Therapeutics Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Party Name | Healome Therapeutics Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, August 24, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, August 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 29, 2023 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, October 31, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, October 31, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, October 31, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, October 31, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, October 31, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, October 31, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 28, 2023 | ASSIGNED TO EXAMINER |
| Monday, December 4, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 5, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, December 5, 2023 | REFUSAL PROCESSED BY MPU |
| Friday, December 8, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, January 3, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, June 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 9, 2024 | FINAL REFUSAL WRITTEN |
| Tuesday, July 9, 2024 | FINAL REFUSAL E-MAILED |
| Tuesday, July 9, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, January 9, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, January 9, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 9, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 22, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, January 22, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, February 4, 2025 | ASSIGNED TO EXAMINER |
| Saturday, February 8, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, March 11, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 11, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 11, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 10, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 10, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 10, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 10, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, October 10, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Friday, October 10, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, October 10, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Friday, October 10, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 5, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 11, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 11, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Saturday, November 29, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |